<DOC>
	<DOCNO>NCT01232075</DOCNO>
	<brief_summary>The aim randomize control trial compare efficacy extend letrozole regimen ( 2.5mg/day cycle day 1 9 ) clomiphene citrate ( 100 mg/day cycle day 3 7 ) woman unexplained infertility undergo superovulation intrauterine insemination .</brief_summary>
	<brief_title>Extended Letrozole Regimen Versus Clomiphene Citrate Superovulation Patients With Unexplained Infertility Undergoing Intrauterine Insemination</brief_title>
	<detailed_description>Unexplained infertility one frequent infertility diagnose encountered gynaecologist . Several study report 10 20 % infertile couple unexplained infertility . Superovulation intrauterine insemination ( IUI ) effective treatment couple unexplained infertility . Superovulation increase probability pregnancy increase number oocyte suitable fertilization correct subtle defect ovulation . Furthermore , IUI increase concentration active motile sperm reach fallopian tube overcomes male factor cervical factor infertility detect conventional test . For four decade , clomiphene citrate first line therapy use induction ovulation woman anovulatory infertility superovulation couple unexplained infertility , mild endometriosis mild male factor infertility . Clomiphene citrate cheap , orally administer , require frequent monitoring associate low risk high-order multiple gestation severe ovarian hyperstimulation syndrome . However , clomiphene citrate cause long lasting depletion estrogen receptor therefore exert antiestrogenic effect estrogen target tissue endocervical mucosa endometrium .Several study reveal clomiphene citrate deleterious effect cervical mucous quantity quality endometrial development result endometrial thinning , luteal phase defect , decrease uterine flow implantation failure . During past decade , letrozole ( aromatase inhibitor approve FDA treatment postmenopausal woman breast cancer ) successfully use induction ovulation anovulatory patient polycystic ovary syndrome augmentation ovulation ovulatory woman . In contrast clomiphene citrate , letrozole rapidly eliminate body deplete estrogen receptor therefore antiestrogenic effect endometrium endocervical mucosa . Several study reveal letrozole use alternative clomiphene citrate superovulation patient unexplained infertility . A metaanalysis seven randomize control trial compare aromatase inhibitor ( letrozole anastrozole ) clomiphene citrate patient unexplained infertility reveal pregnancy rate comparable management option . The optimal dose duration letrozole administration superovulation patient unexplained infertility still clear . In various study report use letrozole superovulation , letrozole administrate cycle 3 7 daily dose range 2.5 7.5 mg .In randomize control trial , AI-Fadhli et al report pregnancy rate significantly high patient unexplained infertility treat 5 mg compare treat 2.5 mg . On hand , randomize control trial compare three dos letrozole ( 2.5,5,7.5 mg/day ) management patient unexplained infertility reveal pregnancy rate comparable three group . The aim randomize control trial compare efficacy extend letrozole regimen ( 2.5mg/day cycle day 1 9 ) clomiphene citrate ( 100 mg/day cycle day 3 7 ) woman unexplained infertility undergo superovulation intrauterine insemination .</detailed_description>
	<mesh_term>Infertility</mesh_term>
	<mesh_term>Clomiphene</mesh_term>
	<mesh_term>Enclomiphene</mesh_term>
	<mesh_term>Zuclomiphene</mesh_term>
	<mesh_term>Letrozole</mesh_term>
	<mesh_term>Chorionic Gonadotropin</mesh_term>
	<mesh_term>Citric Acid</mesh_term>
	<criteria>Patients unexplained infertility Age 18 37 year Period infertility &gt; 1 year Patent Fallopian tube detect hysterosalpingography and/or laparoscopy Normal basal luteinizing hormone ( LH ) , follicle stimulate hormone ( FSH ) prolactin concentration Normal recent semen analysis ( accord World Health Organization criterion ) FSH &gt; 10 IU/L Irregular menstrual cycle Polycystic ovary syndrome Endometriosis Endocrinologic disorder Systemic disease contraindicate pregnancy Previous IUI cycle liver kidney disease</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>37 Years</maximum_age>
	<verification_date>July 2011</verification_date>
	<keyword>Letrozole , Clomiphene citrate , IUI , unexplained infertility</keyword>
</DOC>